---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-040953"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2024-10-11T23:59:59+00:00"
generated_at: "2026-05-30T15:39:44.405699+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics enters $5.1M ATM equity offering with Ladenburg Thalmann

## Summary
- Company may sell up to $5.1M of common stock through ATM facility with Ladenburg Thalmann.
- Commission of 3.0% on gross proceeds; expenses up to $50k reimbursable.
- Shares sold at market prices; offering pursuant to effective S-3 registration statement.
- Company not obligated to sell any shares; can suspend at any time.

## SEC filing metadata
- accession: 0001493152-24-040953
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2024-10-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315224040953/0001493152-24-040953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315224040953/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-040953
- JSON: https://secwatch.observer/filing/0001493152-24-040953.json
- Plain text: https://secwatch.observer/filing/0001493152-24-040953.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.